DICE Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q2 2023

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: DICE Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2023.
DICE Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2023 was -0.74 USD/shares, a 27.6% decline year-over-year.
DICE Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2023 was -2.33 USD/shares.
DICE Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.13 USD/shares, a 46.1% increase from 2021.

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Quarterly (USD/shares)

Earnings Per Share, Basic, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023	-$2	-$1	$0	-27.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	-$2	-$1	$0	-8%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	-$2	$1			Oct 1, 2022	Dec 31, 2022	10-K	2023-03-15
Q3 2022		-$1	+$1.75	+76.1%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-09
Q2 2022		-$1	+$2.69	+82.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022		$1			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q3 2021		-$2			Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021		-$3			Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.